StonvexLoading…
StonvexStonvexStonvexCore line items from NKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $46.31B | $51.36B | $51.22B | $46.71B |
Operating Income | $3.88B | $6.70B | $6.20B | $6.65B |
Net Income | $3.22B | $5.70B | $5.07B | $6.05B |
EPS (Diluted) | $2.16 | $3.73 | $3.23 | $3.75 |
Total Assets | $36.58B | $38.11B | $37.53B | $40.32B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $7.46B | $9.86B | $7.44B | $8.57B |
Free Cash Flow OCF − CapEx | $3.27B | $6.62B | $4.87B | $4.43B |
Shares Outstanding | 1.49B | 1.53B | 1.57B | 1.61B |